Stryker closes acquisition of NOVADAQ Technologies

News Release

Stryker completes acquisition of NOVADAQ Technologies Inc.

Kalamazoo, Michigan – September 1, 2017 – Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of NOVADAQ Technologies Inc. NOVADAQ is a leading developer of fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels, and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures.

As indicated in the June 19, 2017 press release, the transaction is expected to be dilutive to Stryker’s 2017 adjusted net earnings per diluted share by $0.03 – $0.05.

Stryker is one of the world’s leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world. Please contact us for more information at www.stryker.com.

Contacts

For investor inquiries please contact:
Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com

For media inquiries please contact:
Yin Becker, Stryker Corporation, 269-385-2600 or yin.becker@stryker.com